Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Addiction. 2024 Jul 10. doi: 10.1111/add.16609. Online ahead of print.
NO ABSTRACT
PMID:38984463 | DOI:10.1111/add.16609
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Correction to “Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trial”
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Correction to "Changes from 2017 to 2018 in e-cigarette use and in ever marijuana use with e-cigarettes among US adolescents: analysis of the National Youth Tobacco Survey" Correction to "Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials" Correction to "Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials" Impact of the disruption in supply of varenicline since 2021 on smoking cessation in England: A population study Commentary on Aubin et al.: Could combination medication approaches target mental health comorbidity in the context of alcohol use disorder? Commentary on Carrasquilla et al.: Smoking and obesity; uncovering causal mechanisms through triangulation of different methods Commentary on Ussher et al.: Duration and magnitude of postpartum financial incentives for the maintenance of cigarette smoking abstinence Correction to 'The relationship between alcohol use and dementia in adults aged more than 60 years: a combined analysis of prospective, individual-participant data from 15 international studies' Addiction Lives: Maggie Brady Commentary on Belete et al.: Alcohol use prevalence findings for sub-Saharan Africa can be better understood when coupled with a deep appreciation of the continent's diverse cultural contexts and drinking patterns Opportunistic smoking cessation interventions for people accessing financial support settings: A scoping review Para-fluorofentanyl: Coincidence or intentional? E-cigarette policies in Aotearoa (New Zealand): An Indigenous perspective Stakeholders cannot simply wait for the gambling evidence-base to develop: We must all help to build it Navigating the digital age: The need for online-specific gambling marketing regulations Navigating the digital age: The need for online-specific gambling marketing regulations The emergence of nitazenes on the Irish heroin market and national preparation for possible future outbreaks Contingency management as a maintenance intervention in the long-term treatment of substance use disorders Alibi marketing? Surrogate marketing? Brand sharing? What is the correct terminology to discuss marketing for alcohol-free and low-alcohol products which share branding with regular strength alcohol products? Effectiveness of a self-determination theory-based smoking cessation intervention plus instant messaging via mobile application for smokers with cancer: Protocol for a pragmatic randomized controlled trial Effectiveness of a self-determination theory-based smoking cessation intervention plus instant messaging via mobile application for smokers with cancer: Protocol for a pragmatic randomized controlled trial Implications of Switching from Conventional to Electronic Cigarettes on Quality of Life and Smoking Behaviour: Results from the EQualLife Trial Implications of Switching from Conventional to Electronic Cigarettes on Quality of Life and Smoking Behaviour: Results from the EQualLife Trial Alcohol use and alcohol use disorders in sub-Saharan Africa: A systematic review and meta-analysis Alcohol use and alcohol use disorders in sub-Saharan Africa: A systematic review and meta-analysis Cognitive Distortions as Barriers to Seeking Smoking Cessation Treatment: A Comparative Study Electronic cigarettes and subsequent use of cigarettes in young people: An evidence and gap map Not-so-disposable e-cigarettes: Methods young people use to discard single-use e-cigarettes The efficacy of lamotrigine in bipolar disorder: A systematic review and meta-analysis The efficacy of lamotrigine in bipolar disorder: A systematic review and meta-analysis An observational human laboratory assessment of nicotine delivery, vaping topography and subjective effects of usual brand electronic cigarette use among young adults Trajectories of craving in the course of pharmacotherapy trials for methamphetamine use disorder The effectiveness of a standardized tobacco cessation program on psychophysiological parameters in patients with addiction undergoing long-term rehabilitation: a quasi-experimental pilot study Young people's use of disposable vapes: A qualitative study Prevalence of opioid dependence in Scotland 2015-2020: A multi-parameter estimation of prevalence (MPEP) study Unveiling the psychological mechanisms of mutual help groups for addiction recovery: The role of social identity factors Repurposing of dextromethorphan as an adjunct therapy in patients with major depressive disorder: a randomised, group sequential adaptive design, controlled clinical trial protocol Smoking cessation rate and predictors of successful quitting in Jordan: A cross-sectional study Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT-2 trial Harm perceptions across vaping product features: An on-line cross-sectional survey of adults who smoke and/or vape in the United Kingdom Combining app-based behavioral therapy with electronic cigarettes for smoking cessation: a study protocol for a single-arm mixed-methods pilot trial Lithium, the gold standard drug for bipolar disorder: analysis of current clinical studies Vortioxetine for depression in adults: A systematic review and dose-response meta-analysis of randomized controlled trials Cytisine for smoking cessation: A 40-day treatment with an induction period Change in vaping, smoking and dual-use identities predicts quit success and cigarette usage: A prospective study of people quitting smoking with electronic cigarette support Change in vaping, smoking and dual-use identities predicts quit success and cigarette usage: A prospective study of people quitting smoking with electronic cigarette support The phenotypic and genotypic spectrum of individuals with mono- or biallelic ANK3 variants Predictability of buprenorphine-naloxone treatment retention: A multi-site analysis combining electronic health records and machine learning Predictability of buprenorphine-naloxone treatment retention: A multi-site analysis combining electronic health records and machine learning Breaking down barriers: rationalisations and motivation to stop among Chinese male smokers under cigarette dependence The association between alcohol retail access and health care visits attributable to alcohol for individuals with and without a history of alcohol-related health-care use Digital Smoking Cessation Intervention for Cancer Survivors: Analysis of Predictors and Moderators of Engagement and Outcome Alongside a Randomized Controlled Trial Virtual reality cue-exposure therapy in reducing cocaine craving: the Promoting Innovative COgnitive behavioral therapy for Cocaine use disorder (PICOC) study protocol for a randomized controlled trial Incident psychotic experiences following self-reported use of high-potency cannabis: Results from a longitudinal cohort study Personal characteristics associated with switching from Cigarettes to Non-combustible tobacco and nicotine products among U.S. adults: Findings from PATH Study Wave 1 - Wave 5 Personal characteristics associated with switching from Cigarettes to Non-combustible tobacco and nicotine products among U.S. adults: Findings from PATH Study Wave 1 - Wave 5 Changes in self-reported cannabis use in the United States from 1979 to 2022 Somatic and psychiatric comorbidity in people with diagnosed gambling disorder: A Finnish nation-wide register study Correction to 'Why patients diagnosed with bipolar disorder start, continue or discontinue health-related apps supporting their self-management' Distinct patterns of cigarette smoking intensity and other substance use among women who experience housing instability Increased cancer incidence and mortality among people with opioid use-related disorders: A nation-wide cohort study Associations between child maltreatment and hospital admissions for alcohol and other substance use-related disorders up to 40 years of age: Results from the Childhood Adversity and Lifetime Morbidity study Smoking cessation among tuberculosis patients during the coronavirus disease-2019 pandemic Depression screening outcomes among adolescents, young adults, and adults reporting past 30-day tobacco and cannabis use
Evidence Blueprint
Correction to “Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trial”
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Correction to “Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trial”
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
Correction to "Changes from 2017 to 2018 in e-cigarette use and in ever marijuana use with e-cigarettes among US adolescents: analysis of the National Youth Tobacco Survey" Correction to "Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials" Correction to "Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials" Impact of the disruption in supply of varenicline since 2021 on smoking cessation in England: A population study Commentary on Aubin et al.: Could combination medication approaches target mental health comorbidity in the context of alcohol use disorder? Commentary on Carrasquilla et al.: Smoking and obesity; uncovering causal mechanisms through triangulation of different methods Commentary on Ussher et al.: Duration and magnitude of postpartum financial incentives for the maintenance of cigarette smoking abstinence Correction to 'The relationship between alcohol use and dementia in adults aged more than 60 years: a combined analysis of prospective, individual-participant data from 15 international studies' Addiction Lives Addiction Lives: Maggie Brady Commentary on Pardo et al.: Whatever the past situation, drug precursor chemicals may in future represent an important source for synthetic drug production in Afghanistan and surrounding countries Commentary on Belete et al.: Alcohol use prevalence findings for sub-Saharan Africa can be better understood when coupled with a deep appreciation of the continent's diverse cultural contexts and drinking patterns Response to Hall et al.: Prescription psychostimulants for amphetamine-type stimulant use disorder - acknowledging challenges but not giving up on its potential cost-effectiveness Opportunistic smoking cessation interventions for people accessing financial support settings: A scoping review Para-fluorofentanyl: Coincidence or intentional? The systematic review and meta-analysis of cytisine The ChatGPT therapist will see you now: Navigating generative artificial intelligence's potential in addiction medicine research and patient care E-cigarette policies in Aotearoa (New Zealand): An Indigenous perspective Stakeholders cannot simply wait for the gambling evidence-base to develop: We must all help to build it Navigating the digital age: The need for online-specific gambling marketing regulations Navigating the digital age: The need for online-specific gambling marketing regulations The emergence of nitazenes on the Irish heroin market and national preparation for possible future outbreaks Contingency management as a maintenance intervention in the long-term treatment of substance use disorders Commentary on Aminesmaeili et al.: Non-abstinence outcomes in stimulant clinical trials-Why deny improvement? Comment on Domzaridou et al.: Recognising the complexities of co-prescriptions and lifestyle factors in opioid agonist treatment In the balance: No new diagnosis needed in addition to opioid use disorder to study harms associated with long-term opioid therapy Expanding and adapting prevention and treatment options for older adults who engage in harmful use of substances Strengthening oversight and integrity: The multi-faceted role of centralized player tracking systems in gambling Commentary on Booth et al.: Measuring the health burden of homelessness Clinical alcohol guidelines are welcome-but upstream action is paramount Commentary on Socias et al.: It is time to be serious about AUD treatment disparities How research and policy can shape driving under the influence of cannabis How to interpret studies on the impact of legalizing cannabis Opioid problems are changing in Europe with worrying signals that synthetic opioids may play a more significant role in the future Commentary on Fazzino et al.: Proof for why we need cross-industry approaches to research on the commercial determinants of health Chronic obstructive pulmonary disease in heroin users: An underappreciated issue with clinical ramifications Effectiveness of culturally tailoring smoking cessation interventions for reducing or quitting combustible tobacco: A systematic review and meta-analyses Commentary on Brothers et al.: The role of safer environment interventions in addressing injecting-related bacterial and fungal infections Commentary on Kraiss et al.: Read the label - improving the applicability of systematic reviews by coding and analysis of intervention elements E-cigarette support for smoking cessation: Identifying the effectiveness of intervention components in an on-line randomized optimization experiment New perspectives on how to formulate alcohol drinking guidelines: Response to commentaries When harms outweigh benefits of long-term opioid therapy for pain: Need for a new diagnostic entity, research and improved treatments Commentary on Allaf et al.: Comparing countries with different legal cannabis markets can inform on the impact of regulating product type and potency Alibi marketing? Surrogate marketing? Brand sharing? What is the correct terminology to discuss marketing for alcohol-free and low-alcohol products which share branding with regular strength alcohol products? Co-action and changes in alcohol use during a smoking cessation attempt When should we conduct large-scale evaluations? Prazosin and cyproheptadine in combination in the treatment of alcohol use disorder: A randomized, double-blind, placebo-controlled trial Incremental net monetary benefit of using varenicline for smoking cessation: A systematic review and meta-analysis of economic evaluation studies Efficacy and safety of pharmacological intervention for smoking cessation in smokers with diseases: A systematic review and network meta-analysis Varenicline Combined With Oral Nicotine Replacement Therapy and Smartphone-Based Medication Reminders for Smoking Cessation: Feasibility Randomized Controlled Trial Effectiveness of a self-determination theory-based smoking cessation intervention plus instant messaging via mobile application for smokers with cancer: Protocol for a pragmatic randomized controlled trial Effectiveness of a self-determination theory-based smoking cessation intervention plus instant messaging via mobile application for smokers with cancer: Protocol for a pragmatic randomized controlled trial Genetic Prediction of Smoking Cessation Medication Side Effects: A Genome-Wide Investigation of Abnormal Dreams on Varenicline The interaction of e-cigarette use and mental health symptoms on risk of cigarette smoking initiation among young adults in the United States Household vaping bans and youth e-cigarette use Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder Implications of Switching from Conventional to Electronic Cigarettes on Quality of Life and Smoking Behaviour: Results from the EQualLife Trial Implications of Switching from Conventional to Electronic Cigarettes on Quality of Life and Smoking Behaviour: Results from the EQualLife Trial Safety of e-cigarettes and nicotine patches as stop-smoking aids in pregnancy: Secondary analysis of the Pregnancy Trial of E-cigarettes and Patches (PREP) randomized controlled trial Alcohol use and alcohol use disorders in sub-Saharan Africa: A systematic review and meta-analysis Alcohol use and alcohol use disorders in sub-Saharan Africa: A systematic review and meta-analysis Cognitive Distortions as Barriers to Seeking Smoking Cessation Treatment: A Comparative Study Barriers to seeking tobacco cessation services: a qualitative assessment of university students' needs in Qatar Electronic cigarettes and subsequent use of cigarettes in young people: An evidence and gap map